Aptabio, Patent for Contrast Agent-Induced Nephropathy Treatment

[Asia Economy Reporter Junho Hwang] Aptabio announced on the 29th that it has obtained a patent related to a treatment for contrast agent-induced acute renal failure.

The company stated, "This patent concerns pyrazole derivatives useful for renal protection or the prevention and treatment of contrast agent-induced acute renal failure, their manufacturing methods, and pharmaceutical compositions." It added, "Through this patent, we have confirmed renal protective effects in an acute kidney injury model caused by contrast agents, and plan to utilize this for the development of treatments for contrast agent-induced acute renal failure."